Joint Request to File Settlement Agreement as Business Confidential Information Pursuant to 35 U.S.C. 317 and 37 C.F.R. 42.74(c) | May 3, 2017 | PAPER | PATENT OWNER |
Settlement Agreement | May 3, 2017 | EXHIBIT | PATENT OWNER |
Decision - 35 U.S.C. 4264(c), 42.71(a) | Mar 31, 2017 | PAPER | BOARD |
Termination Decision Document | Mar 31, 2017 | PAPER | BOARD |
Order - Cancelling Trial Hearing - 37 CFR 42.70 | Jan 10, 2017 | PAPER | BOARD |
Reply in Support of Petitioner's Motion to Exclude | Dec 30, 2016 | PAPER | PETITIONER |
Patent Owner's Reply to Petitioner's Opposition to Patent Owner's Motion to Exclude Exhibits 1081 &1082 | Dec 30, 2016 | PAPER | PATENT OWNER |
Decision Denying Patent Owner's Request for Rehearing | Dec 28, 2016 | PAPER | BOARD |
Decision Denying Petitioner's Request for Rehearing | Dec 28, 2016 | PAPER | BOARD |
Petitioner's Opposition To Patent Owner's Motion To Exclude Exhibits 1081 & 1082 | Dec 23, 2016 | PAPER | PETITIONER |
Patent Owner's Opposition to Petitioner's Motion to Exclude Pursuant to 37 C.F.R. ¿¿ 42.64(c) | Dec 23, 2016 | PAPER | PATENT OWNER |
Petitioner's Motion for Leave to Withdraw Appearance of Erik B. Flom | Dec 21, 2016 | PAPER | PETITIONER |
Petitioner's Motion to Exclude Evidence Pursuant to 37 C.F.R. 42.64(c) | Dec 9, 2016 | PAPER | PETITIONER |
Petitioner's Request for Oral Argument | Dec 9, 2016 | PAPER | PETITIONER |
Patent Owner's Motion to Exclude Exhibits 1081 & 1082 | Dec 9, 2016 | PAPER | PATENT OWNER |
Petitioner's Second Evidentiary Objections Pursuant to 37 C.F.R. ¿¿ 42.64 | Nov 23, 2016 | PAPER | PETITIONER |
Petitioner's Power of Attorney for Inter partes Review of U.S. Patent No. RE42,096 | Nov 22, 2016 | PAPER | PETITIONER |
Petitioner's Third Revised Mandatory Notices | Nov 22, 2016 | PAPER | PETITIONER |
Patent Owner's Reply to Petitioner's Opposition to Motion to Amend | Nov 17, 2016 | PAPER | PATENT OWNER |
Patent Owner's Updated Exhibit List | Nov 17, 2016 | PAPER | PATENT OWNER |
Email from Trials to Dustin Weeks Re Request for Authorization to File Motion, dated July 14, 2016 at 2:35 PM | Nov 17, 2016 | EXHIBIT | PATENT OWNER |
PTAB E2E Filing Notice Re Patent Owner¿¿¿s Motion to Amend the Claims, dated July 18, 2016 at 4:27 PM | Nov 17, 2016 | EXHIBIT | PATENT OWNER |
PTAB¿¿¿s Top PTAB E2E Tips for Users | Nov 17, 2016 | EXHIBIT | PATENT OWNER |
Email from Dustin Weeks to Erik Flom, dated July 18 at 4.53 PM | Nov 17, 2016 | EXHIBIT | PATENT OWNER |
Email from E2E to Dustin Weeks, dated July 28 at 4.00 PM | Nov 17, 2016 | EXHIBIT | PATENT OWNER |
PTAB E2E Filing Notice 1 July 28 at 5.39 PM | Nov 17, 2016 | EXHIBIT | PATENT OWNER |
Email from Dustin Weeks to E2E, dated July 29 at 8.43 AM | Nov 17, 2016 | EXHIBIT | PATENT OWNER |
Email from Joseph Robinson to Erik Flom, dated July 29 at 2.09 PM | Nov 17, 2016 | EXHIBIT | PATENT OWNER |
Email from Dustin Weeks to Erik Flom, dated July 28 at 3.08 PM | Nov 17, 2016 | EXHIBIT | PATENT OWNER |
E2E Filing Notice 2 July 28 at 5.39 PM | Nov 17, 2016 | EXHIBIT | PATENT OWNER |
Email from Erik Flom to Dustin Weeks, dated July 29 at 11.55 AM | Nov 17, 2016 | EXHIBIT | PATENT OWNER |
Declaration of Dustin Weeks | Nov 17, 2016 | EXHIBIT | PATENT OWNER |
Declaration of Matthew Hu | Nov 17, 2016 | EXHIBIT | PATENT OWNER |
Patent Owner's Second Evidentiary Objections | Oct 24, 2016 | PAPER | PATENT OWNER |
Petitioner's Second Revised Mandatory Notices | Oct 20, 2016 | PAPER | PETITIONER |
Orange Book Entry for Focalin XR | Oct 18, 2016 | EXHIBIT | PETITIONER |
Petitioner's Opposition to Motion to Amend | Oct 18, 2016 | PAPER | PETITIONER |
Petitioner's First Updated Exhibit List | Oct 18, 2016 | PAPER | PETITIONER |
July 18, 2016 Filing Courtesy Notice | Oct 18, 2016 | EXHIBIT | PETITIONER |
July 18, 2016 Email from Erik B. Flom to Dustin B. Weeks | Oct 18, 2016 | EXHIBIT | PETITIONER |
July 28, 2016 Email from Dustin B. Weeks to PTAB | Oct 18, 2016 | EXHIBIT | PETITIONER |
July 29, 2016 Email from Dustin B. Weeks to PTAB E2E Admin | Oct 18, 2016 | EXHIBIT | PETITIONER |
July 29, 2016 Email from Erik B. Flom to PTAB | Oct 18, 2016 | EXHIBIT | PETITIONER |
U.S. Patent Publication No. 2006/0204575 | Oct 18, 2016 | EXHIBIT | PETITIONER |
July 28, 2016 Email from PTAB E2E Admin to Dustin B. Weeks | Oct 18, 2016 | EXHIBIT | PETITIONER |
July 18, 2016 Email from Dustin B. Weeks to Erik B. Flom | Oct 18, 2016 | EXHIBIT | PETITIONER |
Petitioner's First Revised Mandatory Notices | Aug 1, 2016 | PAPER | PETITIONER |
Patent Owner's Motion to Amend | Jul 28, 2016 | PAPER | PATENT OWNER |
Patent Owner's Motion to Amend | Jul 28, 2016 | PAPER | PATENT OWNER |
Patent Owner's Request for Reconsideration and Proposed Order | May 2, 2016 | PAPER | PATENT OWNER |
Motion Presenting Request for Rehearing Under 37 C.F.R. 42.71(d) of Decision Denying-In-Part Institution of Inter Partes Review | May 2, 2016 | PAPER | PETITIONER |
Petitioner's First Evidentiary Objections Pursuant to 37 C.F.R 42.64 | May 2, 2016 | PAPER | PETITIONER |
Patent Owner's First Evidentiary Objections Pursuant to 37 C.F.R 42.64 | May 2, 2016 | PAPER | PATENT OWNER |
Scheduling Order | Apr 19, 2016 | PAPER | BOARD |
Decision - Institution of Inter Partes Review | Apr 18, 2016 | PAPER | BOARD |
Patent Owner's Preliminary Response and Exhibit List | Jan 19, 2016 | PAPER | PATENT OWNER |
FDA Orange Book for Adderall XR | Jan 19, 2016 | EXHIBIT | PATENT OWNER |
Adderall XR Label | Jan 19, 2016 | EXHIBIT | PATENT OWNER |
Complaint, Shire. v. Impax, 03-cv-1164 (DDel) | Jan 19, 2016 | EXHIBIT | PATENT OWNER |
Complaint, Shire v. Sandoz 07-cv-197 (D.Colo.) | Jan 19, 2016 | EXHIBIT | PATENT OWNER |
Complaint, Shire v. Barr 03-cv-1219,6632 (SDNY) | Jan 19, 2016 | EXHIBIT | PATENT OWNER |
Complaint, Shire v. Watson, 11-cv-2340 (SDNY) | Jan 19, 2016 | EXHIBIT | PATENT OWNER |
Complaint, Shire v. Neos 13-cv-1452 (DTx) | Jan 19, 2016 | EXHIBIT | PATENT OWNER |
Claim Construction Stipulation, Watson, DI 83,84 | Jan 19, 2016 | EXHIBIT | PATENT OWNER |
Claim Constructon Order, Neos, DI 69 | Jan 19, 2016 | EXHIBIT | PATENT OWNER |
Burnside, US RE 41148 | Jan 19, 2016 | EXHIBIT | PATENT OWNER |
FH of Burnside, US 6322819 (Chrono Excerpts) | Jan 19, 2016 | EXHIBIT | PATENT OWNER |
FH of Burnside, RE42096 (Chrono Excerpts) | Jan 19, 2016 | EXHIBIT | PATENT OWNER |
FH of Burnside, US 6605300 (Chrono Excerpts) | Jan 19, 2016 | EXHIBIT | PATENT OWNER |
Barr's Para IV in FH of Burnside, RE42096 (IDS 01 Exh. 25) | Jan 19, 2016 | EXHIBIT | PATENT OWNER |
Expert Report Chambliss-Impax from FH of Burnside, RE42096 (IDS 02 Excerpts) | Jan 19, 2016 | EXHIBIT | PATENT OWNER |
Expert Report Klibanov-Shire from FH of Burnside, RE42096 (IDS 02 Excerpts) | Jan 19, 2016 | EXHIBIT | PATENT OWNER |
Pelham (1987) 80 Pediatrics 491 | Jan 19, 2016 | EXHIBIT | PATENT OWNER |
Swanson 1995, ADHD 333 NEJM 944 | Jan 19, 2016 | EXHIBIT | PATENT OWNER |
Ambrosini (2006) LADD.CAT (Safety, Tolerability, Effectiveness) | Jan 19, 2016 | EXHIBIT | PATENT OWNER |
Biederman (2002) Randomized Study (Adderall XR) | Jan 19, 2016 | EXHIBIT | PATENT OWNER |
Swanson (2002) 6 J Atten Disord, New Stimulant Medications | Jan 19, 2016 | EXHIBIT | PATENT OWNER |
Pelham (1995) Pemoline Effects, 34 J. Am. Acad. Child and Adol. Psych. 1504 | Jan 19, 2016 | EXHIBIT | PATENT OWNER |
Dulcan (1990) Using Psychostimulants, 1 J. Child and Adol. Psych. 7 | Jan 19, 2016 | EXHIBIT | PATENT OWNER |
Patrick and Markowitz (1997) Pharmacology of MPH, AMP, Pemoline, 12 Human Psych. 527 | Jan 19, 2016 | EXHIBIT | PATENT OWNER |
Weisler (2005) 6 Expert Opn. Psych 1003 (Adderall XR) | Jan 19, 2016 | EXHIBIT | PATENT OWNER |
Adderall Label | Jan 19, 2016 | EXHIBIT | PATENT OWNER |
Spencer, Arch Gen Psychiatry. 2001 Aug - 58(8) 775-82 | Jan 19, 2016 | EXHIBIT | PATENT OWNER |
McGough, J. AM. ACAD. CHILD ADOLESC. PSYCHIATRY, 426, JUNE 2003 | Jan 19, 2016 | EXHIBIT | PATENT OWNER |
Pliszka, Pediatric Clinics of North America, 45-5, 1085-1098 (1 October 1998)(mixed) | Jan 19, 2016 | EXHIBIT | PATENT OWNER |
SUPAC-MR- Modified Release Solid Oral Dosage Forms (Sept. 1997) (1997 FDA Guidance) | Jan 19, 2016 | EXHIBIT | PATENT OWNER |
Amerigen Markman Order, DI 100 | Jan 19, 2016 | EXHIBIT | PATENT OWNER |
Complaint, Shire v. Colony | Jan 19, 2016 | EXHIBIT | PATENT OWNER |
RE '096 Patent, Figs. 3 and 4 | Jan 19, 2016 | EXHIBIT | PATENT OWNER |
Annotated Fig. 1 of Mehta, US 5837284 | Jan 19, 2016 | EXHIBIT | PATENT OWNER |
Power of Attorney | Nov 3, 2015 | PAPER | INDICATES ARTIFACT WAS SUBMITTED ON BEHALF OF POTENTIAL_PATENT OWNER. |
Related Matters | Nov 3, 2015 | PAPER | INDICATES ARTIFACT WAS SUBMITTED ON BEHALF OF POTENTIAL_PATENT OWNER. |
Notice of Filing Date Accorded | Oct 19, 2015 | PAPER | BOARD |
Petition for Inter Partes Review of USPN RE42,096 under 35 U.S.C. Secs. 311-319 and 37 C.F.R. 42.1-42.80 and 42.100-42.123 | Oct 1, 2015 | PAPER | PETITIONER |
Petitioner's Power of Attorney for Inter Partes Review of U.S. Patent No. RE42,096 | Oct 1, 2015 | PAPER | PETITIONER |
Power of Attorney | Oct 1, 2015 | PAPER | PETITIONER |
U.S. Patent No. RE42,096 C1 | Oct 1, 2015 | EXHIBIT | PETITIONER |
US Patent No 6322819 File History, Sept 9 1999 Amendment | Oct 1, 2015 | EXHIBIT | PETITIONER |
U.S. Patent No. 5,837,284 | Oct 1, 2015 | EXHIBIT | PETITIONER |
Selected Portions of 1997 Physicians Desk Reference 51st ed. 1997 | Oct 1, 2015 | EXHIBIT | PETITIONER |
Declaration of Edmund J. Elder, Jr., Ph.D., R.Ph. | Oct 1, 2015 | EXHIBIT | PETITIONER |
Selected Portions of 1995 United States Pharmacopeia and National Formulary, USP 23-NF 18 1994 | Oct 1, 2015 | EXHIBIT | PETITIONER |
Chiao, Robinson Sustained-Release Delivery Systems, in REMINGTON THE SCIENCE AND PRACTICE OF PHARMACY, 1660, 19th ed. 1995 | Oct 1, 2015 | EXHIBIT | PETITIONER |
Selected Portions of ANSEL, POPOVICH and ALLEN, PHARMACEUTICAL DOSAGE FORMS AND DRUG DELIVERY SYSTEMS, 6th ed. 1995 | Oct 1, 2015 | EXHIBIT | PETITIONER |
Selected Portions of Hoffman and Lefkowitz, Catecholamines, Sympathomimetic Drugs, and Adrenergic Receptor Antagonists, in GOODMAN and GILMANS THE PHARMACOLOGICAL BASIS OF THERAPEUTICS, 199, 9th ed. 1996 | Oct 1, 2015 | EXHIBIT | PETITIONER |
Selected Portions of Answering Expert Report of Robert Langer, Sc.D. Regarding United States Patent Nos. 6,322,819 and 6,605,300, Shire Labs, Inc. v. Barr Labs., Inc., Case No. 03-cv-1219PKC, -6632PKC, S.D.N.Y. April 25, 2005 | Oct 1, 2015 | EXHIBIT | PETITIONER |
Selected Portions of ELIEL and WILEN, STEREOCHEMISTRY OF ORGANIC COMPOUNDS, 167, Wiley 1994 | Oct 1, 2015 | EXHIBIT | PETITIONER |
Selected Portions of AMERICAN HERITAGE COLLEGE DICTIONARY, 874, 3rd ed. 1997 | Oct 1, 2015 | EXHIBIT | PETITIONER |
Selected Portions of DOYLE and MUNGALL, EXPERIMENTAL OR-GANIC CHEMISTRY, 37-38, Wiley 1980 | Oct 1, 2015 | EXHIBIT | PETITIONER |
Selected Portions of J. CHILD and ADOLESCENT PSYCH., Oct. 1994 | Oct 1, 2015 | EXHIBIT | PETITIONER |
Earl Rosen et al., Absorption and Excretion of Radioactively Tagged Dextroamphetamine Sulfate From a Sustained-Release Preparation, JAMA, Vol. 194, No. 11, 145, 1965) | Oct 1, 2015 | EXHIBIT | PETITIONER |
Stuart C. Porter, Coating of Pharmaceutical Dosage Forms, in REMINGTON- THE SCIENCE AND PRACTICE OF PHARMACY, 1650,19th ed. 1995 | Oct 1, 2015 | EXHIBIT | PETITIONER |
U.S. Patent No. 6,322,819 - filed Oct. 21, 1998 | Oct 1, 2015 | EXHIBIT | PETITIONER |
CV of Edmund J. Elder, Jr., Ph.D., R.Ph. | Oct 1, 2015 | EXHIBIT | PETITIONER |
Order Construing the Terms of U.S. Patent Nos. 6,322,819 and 6,605,300, Shire Labs., Inc. v. Impax Labs., Inc., Case No. 03-1164GMS, D. Del. Feb. 9, 2005) | Oct 1, 2015 | EXHIBIT | PETITIONER |
Order and Memorandum of Decision, Shire LLC v. Sandoz, Inc., Case No. 07-cv-197, D. Colo. Sept. 24, 2008 | Oct 1, 2015 | EXHIBIT | PETITIONER |
Policy on Period of Marketing Exclusivity for Newly Approved Drug Products with Enantiomer Active Ingredients, Request for Comments, 62 Fed. Reg. 2,167, Jan. 15, 1997 | Oct 1, 2015 | EXHIBIT | PETITIONER |
Selected Portions of Edward Stempel, Prolonged-Action Medication, in DISPENSING OF MEDICATION, 1002, Eric W. Martin ed., Mack 1971 | Oct 1, 2015 | EXHIBIT | PETITIONER |
James R. McCowan, Coating, in DISPENSING OF MEDICATION, 812, Eric W. Martin ed., 7th ed. 1971 | Oct 1, 2015 | EXHIBIT | PETITIONER |
US Patent 6322819 File History, Nov 9 1999 Office Action | Oct 1, 2015 | EXHIBIT | PETITIONER |
STREITWEISER and HEATHCOCK, INTRODUCTION TO ORGANIC CHEMISTRY, 2d ed. MacMillan 1981 | Oct 1, 2015 | EXHIBIT | PETITIONER |
Shire LLC, Shire US Inc., and Shire Development LLCs Opening Claim Construction Brief, June 29, 2015, filed in Shire LLC v. Corepharma, LLC, 14 05694, D.N.J.,filed June 29, 2015 | Oct 1, 2015 | EXHIBIT | PETITIONER |
US Patent RE42096 File History, Nov 23 2003 IDS | Oct 1, 2015 | EXHIBIT | PETITIONER |
US Patent No 6322819 File History, May 11 2001 Interview Summary | Oct 1, 2015 | EXHIBIT | PETITIONER |
Methylphenidate, A Background Paper, U.S. Dept. of Justice Drug Enforcement Administration, Oct. 1995 | Oct 1, 2015 | EXHIBIT | PETITIONER |
US Patent No RE42096 - Mar 3 2008 Amendment Req for Reconsideration After NonFinal Rejection | Oct 1, 2015 | EXHIBIT | PETITIONER |
US Appl 09176542, Aug 1 2001 Interview Summary | Oct 1, 2015 | EXHIBIT | PETITIONER |
Physicians Desk Reference, 1997, Copyright Office Public Catalog Entry | Oct 1, 2015 | EXHIBIT | PETITIONER |
National Criminal Justice Reference Service Abstract for Methylphenidate, A Background Paper | Oct 1, 2015 | EXHIBIT | PETITIONER |
Selected Portions of Donald N. Franz, Sympathomimetic Drugs, in REMINGTON, THE SCIENCE AND PRACTICE OF PHARMACY, Chapter 57, 981, 987, 19th ed. 1995 | Oct 1, 2015 | EXHIBIT | PETITIONER |
Selected Portions of Handbook of Pharmaceutical Excipients, Hydroxypropyl Methylcellulose, 229, 2d ed. 1994 | Oct 1, 2015 | EXHIBIT | PETITIONER |
Selected Portions of The Feynman Lectures on Physics, Chapter 43, 43-4, 1963 | Oct 1, 2015 | EXHIBIT | PETITIONER |
Selected Portions of DICTIONARY OF PHARMACY, Julian H. Fincher, ed., 1986 | Oct 1, 2015 | EXHIBIT | PETITIONER |
Selected Portions of Multiparticulate Oral Drug Delivery, Isaac - Ghebre-Sellasie ed., 1994 | Oct 1, 2015 | EXHIBIT | PETITIONER |
WO 1998042379 A2 | Oct 1, 2015 | EXHIBIT | PETITIONER |
US Patent No 6322819 File History, Oct 21 1998 New Application Transmittal, Specification, Claims, Drawings and Oath | Oct 1, 2015 | EXHIBIT | PETITIONER |
US Patent No 6322819, File History, Jun 25 2001 Amendment | Oct 1, 2015 | EXHIBIT | PETITIONER |
US Patent No 6322819 File History, July 20 2001 Office Action | Oct 1, 2015 | EXHIBIT | PETITIONER |
W. H. Hartung and J. C. Munch, Amino Alcohols, VI. The Preparation and Pharmacodynamic Activity of Four Isomeric Phenylpropylamines, 53 J. AM. CHEM. SOC. 1875, 1931 | Oct 1, 2015 | EXHIBIT | PETITIONER |
Selected Portions of 1974 PHYSICIANS DESK REFERENCE, Obetrol 1201, 28th ed. 1974 | Oct 1, 2015 | EXHIBIT | PETITIONER |
Selected Portions of 1993 PHYSICIANS DESK REFERENCE, Obetrol 1907, 47th ed. 1992 | Oct 1, 2015 | EXHIBIT | PETITIONER |
Selected Portions of 1995 PHYSICIANS DESK REFERENCE, Obetrol and Adderall 1959-61, 49th ed. 1994 | Oct 1, 2015 | EXHIBIT | PETITIONER |
US Patent No 6322819 File History, Aug 13 2001 Notice of Allowance and Issue Fee Due | Oct 1, 2015 | EXHIBIT | PETITIONER |
Copyright Catalog entry for 1993 Physicians Desk Reference | Oct 1, 2015 | EXHIBIT | PETITIONER |
Copyright Catalog entry for 1995 Physicians Desk Reference | Oct 1, 2015 | EXHIBIT | PETITIONER |
Selected Portions of Fink and Simonsmeier, Laws Governing Pharmacy, in REMINGTON-THE SCIENCE AND PRACTICE OF PHARMACY, 1892, 1900, 19th ed. 1995 | Oct 1, 2015 | EXHIBIT | PETITIONER |
Selected Portions of Marianne Perie et al., Time Spent Teaching Core Academic Subjects in Elementary Schools-Comparisons Across Community, School, Teacher and Student Characteristics, Feb. 1997 | Oct 1, 2015 | EXHIBIT | PETITIONER |
Selected Portions of Kris Holt, Bioequivalence Studies of Ketoprofen-Product Formulation, Pharmacokinetics, Deconvolution, and in vitro-in vivo Correlations, Aug. 20, 1997, Ph.D. Dissertation submitted to Oregon State University | Oct 1, 2015 | EXHIBIT | PETITIONER |
US Patent RE42096, Jun 22 2007 Non-Final Rejection | Oct 1, 2015 | EXHIBIT | PETITIONER |
US Patent RE42096 Sept 24 2007 Amendment | Oct 1, 2015 | EXHIBIT | PETITIONER |
US Patent RE42096 Mar 6 2008 Amendment | Oct 1, 2015 | EXHIBIT | PETITIONER |
US Patent RE42096 July 24 2008 Office Action | Oct 1, 2015 | EXHIBIT | PETITIONER |
US Patent RE42096 Oct 24 2008 Amendment | Oct 1, 2015 | EXHIBIT | PETITIONER |
Keith Marshall and Edward M. Rudnick, Tablet Dosage Forms, in MODERN PHARMACEUTICS, 361, Banker and Rhodes, eds., 2d ed. 1990 | Oct 1, 2015 | EXHIBIT | PETITIONER |
US Patent RE42096 Oct 3 2005 Office Action | Oct 1, 2015 | EXHIBIT | PETITIONER |
David M. Jones and Phillip J. Percel, Coating of Multiparticulates-Molten Materials, in MULTIPARTICULATE ORAL DRUG DELIVERY, 113, 1994 | Oct 1, 2015 | EXHIBIT | PETITIONER |
Robert A. Castello, et al., Discoloration of Tablets Containing Lactose, J. PHAR. SCI., Vol. 51, No. 2, 106, 1962 | Oct 1, 2015 | EXHIBIT | PETITIONER |
B. Sue Brizuela and Judith A. Hesp, Drug Information, in REMINGTON-THE SCIENCE AND PRACTICE OF PHARMACY, 42, 19th ed. 1995 | Oct 1, 2015 | EXHIBIT | PETITIONER |
Patricia K. Sonsalia, Central Nervous System Stimulants, in REMINGTON -THE SCIENCE AND PRACTICE OF PHARMACY, 1231, 1234, 19th ed. 1995 | Oct 1, 2015 | EXHIBIT | PETITIONER |
Vijay Kumar and Gilbert S. Banker, Maillard Reactions and Drug Stability, in MAILLARD REACTIONS IN CHEMISTRY FOOD AND HEALTH, 20, Theodore P. Labuza, et al., eds., 1994 | Oct 1, 2015 | EXHIBIT | PETITIONER |
WO 1997025064 A1 | Oct 1, 2015 | EXHIBIT | PETITIONER |
Selected Portions of The Merck Index, Susan Budavari, et al., eds., 11th ed. 1989 | Oct 1, 2015 | EXHIBIT | PETITIONER |
Copyright Catalog entry for Goodman and Gilmans | Oct 1, 2015 | EXHIBIT | PETITIONER |
US Patent RE42096 Mar 24 2005 Preliminary Amendment | Oct 1, 2015 | EXHIBIT | PETITIONER |
US Patent RE42096 Exhibit 6 to Sept 24 2007 Amendment, PubMed Abstract of T. Kraemer and H. Maurer, J. CHROMAT. BIOMED. SCI. APPL., 1998 Aug 21-713-1-163-87 | Oct 1, 2015 | EXHIBIT | PETITIONER |
US Patent RE42096 Exhibit 7 to Sept 24 2007 Amendment, PubMed Abstract of Wong et al., J. Clin. Pharmacol., 1998 Oct-38-10, 971-8 | Oct 1, 2015 | EXHIBIT | PETITIONER |
US Patent 6322819 Aug 1 2001 Amendment and Remarks | Oct 1, 2015 | EXHIBIT | PETITIONER |
21 U.S.C. Sec. 812b2, 1994 and Jan. 6, 1997 Supp. | Oct 1, 2015 | EXHIBIT | PETITIONER |
Declaration of Deborah L. Grimm | Oct 1, 2015 | EXHIBIT | PETITIONER |
Thomas Kraemer and Hans H. Maurer, J. CHROMAT. BIOMED. SCI. APPL., Vol. 713, 163, 1998 | Oct 1, 2015 | EXHIBIT | PETITIONER |
Y. Nancy Wong, et al., Comparison of the Single-Dose Pharmacokinetics and Tolerability of Modafinil and Dextroamphetamine Administered Alone or in Combination in Healthy Male Volunteers, J. CLIN. PHARMACOL., Vol. 38, 971, 1998 | Oct 1, 2015 | EXHIBIT | PETITIONER |
Selected Portions of Kenneth A. Connors, et al., CHEMICAL STABILITY OF PHARMACEUTICALS, 82, 2d ed. 1986 | Oct 1, 2015 | EXHIBIT | PETITIONER |
US Patent RE42096 Sept 24 2007 Amendment | Oct 1, 2015 | EXHIBIT | PETITIONER |
Letter from Robert Temple, Director, Office of Drug Evaluation to William A. Neurge, Chief Operating Officer, Richwood Pharma Co., Feb. 13, 1996 | Oct 1, 2015 | EXHIBIT | PETITIONER |
US Patent 6322819 Mar 2 2000 Response to Office Action | Oct 1, 2015 | EXHIBIT | PETITIONER |
Joseph B. Schwartz, Joel R. Flamholz and Robert H. Press, Computer Optimization of Pharmacaeutical Formulations 1-General Procedure, 62 J. Pharm. Sci. 1165, 1973 | Oct 1, 2015 | EXHIBIT | PETITIONER |